RGS2 and Huntington disease: Decreased striatal RGS2 expression has been suggested to be neuroprotective in Huntington's disease (HD).44 A similar compensatory response may underlie the lower RGS2 expression observed in our AD LCLs (Figure 3a) and in postmortem AD brain tissues (Figures 4d–f).